Tue, Jul 29, 2014, 3:44 AM EDT - U.S. Markets open in 5 hrs 46 mins

Recent

% | $
Click the to save as a favorite.

Puma Biotechnology, Inc. Message Board

  • doc_3377 doc_3377 Feb 6, 2014 7:52 PM Flag

    Good outcome of patent situation in Europe!!

    Here's the link

    http://www.marketwatch.com/story/puma-biotechnology-announces-positive-outcome-of-european-opposition-proceedings-2014-02-06?reflink=MW_news_stmp

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The patent (EP 1848414) includes the claim "for the pharmaceutical composition comprising an irreversible EGFR inhibitor for use in treating cancer in a subject having a T790M mutation". Boehringer Ingelheim's marketed drug, afatinib (Gilotrif ), is being sold or this use, It would seem that BI is now infringing the Puma patent and would need to obtain a license and pay royalties to continue to sell this drug.

      Sentiment: Strong Buy

 
PBYI
198.01-2.67(-1.33%)Jul 28 4:02 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.